Biotherapies

Biotherapies, Inc. is a biotechnology company focused on the discovery and development of tissue-specific growth inhibitory proteins for the treatment and diagnosis of cancer. The company's lead platform is based on Mammastatin, a naturally occurring protein that inhibits the growth of mammary epithelial cells and is being developed as a therapeutic and diagnostic for breast cancer. Beyond its internal research, Biotherapies offers contract research and service offerings to complement its cancer product development. Headquartered in San Jose, California, the company aims to leverage its protein-based technology to address a broad range of human cancers by identifying similar growth inhibitors in other tissues.